Innovent Biologics Inc.

Innovent Biologics Inc. Stock

105.11P/E
€17.31BMarket capitalisation
CN¥0.68Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Innovent Biologics is one of the leading biotechnology companies in China. Listed on the Hong Kong stock exchange in 2018, Innovent has 12 commercialized oncology products and four commercialized nononcology products as of January 2026, and 34 drugs in its research and development pipeline. Its core assets are Tyvyt, a PD-1 inhibitor included in the National Reimbursement Drug Lists (NRDL) for the first-line treatment of five major cancers, and mazdutide, a GLP-1/glucagon dual agonist drug for weight loss, fat breakdown, and Type 2 diabetes. Mazdutide is the first domestic GLP-1 drug produced and competes with Eli Lilly and Novo Nordisk in China. Tyvyt's main competition includes drugs from Junshi, Jiangsu Hengrui, BeOne, Merck, and Bristol Myers.

Innovent Biologics Inc. is registered in the following country: Cayman Islands (Exchange: HKSEHK).

Key metrics

Key metrics and master data for the Innovent Biologics Inc. stock.

Market capitalisation
€17.31B
P/E
105.11
P/B
5.66
P/S
8.12
P/CF
9.04
Issued shares 2B Units

Return

Here you can see the performance of the Innovent Biologics Inc. stock.

PeriodPerfor­mance
1 Week-6.93 %
1 Month-9.24 %
3 Months-13.71 %
6 Months+6.48 %
1 Year-5.65 %
YTD+8.86 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Innovent Biologics Inc. share.

DateRatio
No data available.

Which ETF contains the Innovent Biologics Inc. stock?

The Innovent Biologics Inc. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Innovent Biologics Inc. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Innovent Biologics Inc. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.